Tunçay, S. Et Al. 2021. What is the Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A. Saudi Journal of Kidney Diseases and Transplantation , vol.32, no.4 , 1019-1027.

Tunçay, S., Mir, S., & Hakverdi, G., (2021). What is the Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A. Saudi Journal of Kidney Diseases and Transplantation , vol.32, no.4, 1019-1027.

Tunçay, Seçil, Sevgi Mir, And GÜLDEN HAKVERDİ. "What is the Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A," Saudi Journal of Kidney Diseases and Transplantation , vol.32, no.4, 1019-1027, 2021

Tunçay, Seçil Et Al. "What is the Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A." Saudi Journal of Kidney Diseases and Transplantation , vol.32, no.4, pp.1019-1027, 2021

Tunçay, S. Mir, S. And Hakverdi, G. (2021) . "What is the Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A." Saudi Journal of Kidney Diseases and Transplantation , vol.32, no.4, pp.1019-1027.

@article{article, author={Seçil Tunçay Et Al. }, title={What is the Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A}, journal={Saudi Journal of Kidney Diseases and Transplantation}, year=2021, pages={1019-1027} }